Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Pet cancer therapy specialist VetDC has said findings from a new study support the efficacy of its Tanovea-CA1 canine lymphoma treatment.
The European Medicines Agency (EMA) has found sales of antibiotics for animal use decreased by 13% in Europe between 2011 and 2015.
Pet health specialist Aratana Therapeutics is making its Entyce appetite stimulant for dogs available to US veterinarians.
European authorities have given the go-ahead for the addition of cats to the label of Zoetis' SevoFlo.
Antimicrobial consumption by animals in Denmark in 2016 fell by a substantial 5%.
Charlie Munger, a leading US investment guru and stock market expert once said: "Too little attention in economics [is given] to second-order and even higher-order effects. This defect is quite understandable because consequences have consequences and consequences of the consequences have consequences and so on."
A panel of experts discussed the future of the fish health sector at the recent Aquaculture Innovation Summit in London. Animal Pharm editor Joseph Harvey attended to hear about an industry searching for next-generation answers to its unmet needs.
Japanese authorities have placed specific limitations on the use of cefquinome, a veterinary cephalosporin.
Australian border guards at airports have recently spent a week seeking out illicit pet medicines being imported from abroad and seized a number of suspicious packages.
US firm Assisi Research Laboratories has been granted a minor use minor species (MUMS) designation for a canine cancer treatment.
Belgian company ViroVet has added another €1.5 million ($1.76 million) to its working capital after completing the second closing of its series A financing round.
US veterinary distributor MWI Animal Health is to pump cash into a start-up specializing in treatment of arthritis and rheumatoid conditions in companion animals.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.